Australian Cancer Technology Pty Ltd
Company developing three approaches for cures; Chk1 kinase inhibitor, mutated p53 gene and retroviral display vaccines. Includes announcements, media releases, overview of projects incollaboration with UK, a hospital in Sydney, and corporate details at West Perth, Western Australia
austcancer.com.au
Title: Australian Cancer Technology Pty Ltd
Description: Australian Cancer Technology is a publicly listed company developing the Pentrix
cancer vaccine with St Vincent’s Hospital in Sydney, based on the p53 molecule
as well as supporting additional cancer therapy research and biotechnology
projects.
Keywords: pentrix cancer vaccine biotechnology st vincents heregulin breast cancer
